Hold Natco Pharma, target price Rs 660: ICICI Direct

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 10403.02 Crore) operating in Pharmaceuticals sector.

Agencies
Promoters held 48.8 per cent stake in the company as of 30-Sep-2022, while FIIs owned 19.13 per cent, DIIs 14.3 per cent.
ICICI Direct has hold call on Natco Pharma with a target price of Rs 660. The current market price of Natco Pharma is Rs 571.8.

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 10403.02 Crore) operating in Pharmaceuticals sector.

Natco Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Job Work, Export Incentives, Scrap for the year ending 31-Mar-2022.



Financials
For the quarter ended 30-09-2022, the company reported a Consolidated Total Income of Rs 452.60 Crore, down -50.75 % from last quarter Total Income of Rs 918.90 Crore and up 9.01 % from last year same quarter Total Income of Rs 415.20 Crore. Company reported net profit after tax of Rs 56.80 Crore in latest quarter.


ADVERTISEMENT

Promoter/FII Holdings
Promoters held 48.8 per cent stake in the company as of 30-Sep-2022, while FIIs owned 19.13 per cent, DIIs 14.3 per cent.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Hold Natco Pharma, target price Rs 660: ICICI Direct
Text Size:AAA
Success
This article has been saved

*

+